NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,703,209 | +12.5% | 490,468 | +23.7% | 0.55% | +31.0% |
Q2 2023 | $19,299,578 | +56.4% | 396,621 | +78.5% | 0.42% | +75.5% |
Q1 2023 | $12,336,877 | +60138.7% | 222,206 | -56.4% | 0.24% | -30.5% |
Q4 2022 | $20,480 | -99.7% | 509,822 | +232.2% | 0.35% | +273.1% |
Q3 2022 | $6,724,000 | +9.1% | 153,452 | -11.7% | 0.09% | +45.3% |
Q2 2022 | $6,162,000 | +12.3% | 173,871 | +28.9% | 0.06% | +8.5% |
Q1 2022 | $5,488,000 | +13.9% | 134,916 | +161.4% | 0.06% | +22.9% |
Q4 2021 | $4,820,000 | +249.8% | 51,613 | +317.3% | 0.05% | +242.9% |
Q3 2021 | $1,378,000 | +81.8% | 12,367 | +85.3% | 0.01% | +100.0% |
Q2 2021 | $758,000 | – | 6,674 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |